Company Filing History:
Years Active: 2005
Title: Andrea Kolbus: Innovator in Genetically Modified Fibroblast Cells
Introduction
Andrea Kolbus is a prominent inventor based in Rastatt, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of genetically modified fibroblast cells. Her innovative work has the potential to impact the treatment and diagnosis of diseases related to keratinocyte proliferation and differentiation.
Latest Patents
Andrea Kolbus holds a patent for genetically modified fibroblast cells. This invention involves fibroblast cells that have specific modifications, including the inactivation of a gene encoding a subunit of the transcription factor AP-1. The cells are designed to express the active subunit only after the promoter is induced, allowing for controlled expression. This technology can be utilized to identify compounds that influence keratinocyte behavior, which is crucial for understanding and treating various skin-related diseases.
Career Highlights
Andrea Kolbus is affiliated with the Deutsche Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where she conducts her research. Her work has garnered attention for its innovative approach to genetic modification and its implications for medical research.
Collaborations
Throughout her career, Andrea has collaborated with notable colleagues, including Peter Angel and Norbert Fusenig. These partnerships have enhanced her research and contributed to the advancement of knowledge in her field.
Conclusion
Andrea Kolbus is a trailblazer in the realm of genetic engineering, with her patented work on fibroblast cells paving the way for future advancements in medical treatments. Her contributions are vital to the ongoing research in keratinocyte-related diseases.